Tactic Links - Organic Traffic Booster - Home

Path: Home > List > Load (astrazenecaconnect.net)

domain	astrazenecaconnect.net
summary	CALQUENCE, a new drug developed by AstraZeneca, has been approved in Europe for the treatment of adult patients with previously untreated chronic lymphocytic leukemia (CLL) or those who have undergone at least one prior treatment for CLL combined with obinutuzumab or monotherapy. The approval is expected to improve patient survival and quality of life by enabling earlier detection and treatment of this type of cancer.
title	Information for healthcare professionals \| AZ Connect
description	On our AstraZeneca Connect service portal, we have collected information that you as a healthcare professional may often need.
keywords	diabetes, information, till, cancer, study, post, event
upstreams
downstreams
nslookup	A 217.114.94.2
created	2025-11-08
updated	2025-11-25
summarized	2025-11-26